Picture of Bb Biotech logo

BION Bb Biotech News Story

0.000.00%
ch flag iconLast trade - 00:00
FinancialsBalancedMid CapSuper Stock

Brief: BB Biotech FY Net Profit At CHF 76 Mln

Jan 24 (Reuters) - BB BIOTECH AG  BION.S :
    * FULL-YEAR 2024: BB BIOTECH SHARES DELIVERED A TOTAL RETURN
OF
-13.5% IN CHF AND -14.1% IN EUR
    * BB BIOTECH AG - NAV PERFORMANCE AMOUNTED TO +3.0% IN CHF,
+1.7%
IN EUR AND -4.6% IN USD FOR 2024 (INCLUDING DIVIDEND)
    * BB BIOTECH AG - FULL-YEAR 2024 NET PROFIT OF CHF 76 MN,
COMPARED
TO A NET LOSS OF CHF 207 MN IN 2023
    * BB BIOTECH AG - Q4 BB BIOTECH SHARES RETURNED -2.7% IN CHF
AND
-3.5% IN EUR
    * BB BIOTECH AG - FOURTH-QUARTER NET PROFIT OF CHF 60 MN,
COMPARED
TO A NET PROFIT OF CHF 109 MN IN Q4 2023
    * BB BIOTECH AG - BOARD OF DIRECTORS WILL PROPOSE A REGULAR
DIVIDEND OF CHF 1.80 PER SHARE AT ANNUAL GENERAL MEETING ON
MARCH 19, 2025

Source text:  ID:nEQ4Tnjtva 
Further company coverage:  BION.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Bb Biotech

See all news